What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Virus
Internal medicine, Cervical cancer, Immunology, Gynecology and Risk factor are his primary areas of study.
Matti Lehtinen interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
The concepts of his Cervical cancer study are interwoven with issues in Serology and Vaccine efficacy, Vaccination.
His studies in Vaccination integrate themes in fields like Public health and Human papillomavirus.
His research integrates issues of Sexually transmitted disease and Virology in his study of Immunology.
His Risk factor research integrates issues from Odds ratio, Cancer, Chlamydia trachomatis, Case-control study and Prospective cohort study.
His most cited work include:
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (1649 citations)
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. (1307 citations)
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial (1140 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Immunology, Vaccination, Cervical cancer and Virology.
Internal medicine is closely attributed to Oncology in his work.
His Vaccination study combines topics from a wide range of disciplines, such as Incidence, HPV infection and Human papillomavirus.
His Cervical cancer research includes elements of Cancer registry, Gynecology and Clinical trial.
The Virology study combines topics in areas such as Epitope, Antigen and Molecular biology.
In his research on the topic of Risk factor, Pregnancy is strongly related with Case-control study.
He most often published in these fields:
- Internal medicine (38.78%)
- Immunology (32.13%)
- Vaccination (39.34%)
What were the highlights of his more recent work (between 2013-2021)?
- Vaccination (39.34%)
- Internal medicine (38.78%)
- Human papillomavirus (19.11%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Vaccination, Internal medicine, Human papillomavirus, Randomized controlled trial and Cervical cancer.
His Vaccination research is multidisciplinary, incorporating elements of Young adult, Cervical intraepithelial neoplasia and Incidence.
Matti Lehtinen has included themes like Gynecology, Vaccine trial, Immunology and HPV infection in his Cervical intraepithelial neoplasia study.
His Internal medicine research focuses on subjects like Oncology, which are linked to Ovarian cancer and Risk factor.
The study incorporates disciplines such as Disease and Artificial intelligence in addition to Cervical cancer.
Matti Lehtinen focuses mostly in the field of Cohort, narrowing it down to topics relating to HPV vaccines and, in certain cases, Antibody.
Between 2013 and 2021, his most popular works were:
- HPV-FASTER: broadening the scope for prevention of HPV-related cancer. (106 citations)
- Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study (67 citations)
- Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial (67 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Virus
His primary areas of study are Vaccination, Internal medicine, Vaccine efficacy, Cervical cancer and Randomized controlled trial.
Immunology covers Matti Lehtinen research in Vaccination.
In his work, Risk factor and Cancer is strongly intertwined with Oncology, which is a subfield of Internal medicine.
His research in Vaccine efficacy tackles topics such as Herd immunity which are related to areas like Papillomavirus Vaccines, Herd and Human papillomavirus.
Matti Lehtinen combines subjects such as Mass screening, Cancer prevention and Environmental health with his study of Cervical cancer.
While the research belongs to areas of Cervical intraepithelial neoplasia, he spends his time largely on the problem of HPV infection, intersecting his research to questions surrounding Colposcopy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
